Galactosyltransferase B4GALT1 confers chemoresistance in pancreatic ductal adenocarcinomas by upregulating N-linked glycosylation of CDK11p110.

MLA

Chen, Yitian, et al. “Galactosyltransferase B4GALT1 Confers Chemoresistance in Pancreatic Ductal Adenocarcinomas by Upregulating N-Linked Glycosylation of CDK11p110.” Cancer Letters, vol. 500, Mar. 2021, pp. 228–43. EBSCOhost, https://doi.org/10.1016/j.canlet.2020.12.006.

APA

Chen, Y., Su, L., Huang, C., Wu, S., Qiu, X., Zhao, X., Meng, Q., Meng, Y.-M., Kong, X., Wang, M., Liu, C., & Wong, P.-P. (2021). Galactosyltransferase B4GALT1 confers chemoresistance in pancreatic ductal adenocarcinomas by upregulating N-linked glycosylation of CDK11p110. Cancer Letters, 500, 228–243. https://doi.org/10.1016/j.canlet.2020.12.006

Chicago

Chen, Yitian, Liangping Su, Cheng Huang, Sangqing Wu, Xiaoyi Qiu, Xinbao Zhao, Qiong Meng, et al. 2021. “Galactosyltransferase B4GALT1 Confers Chemoresistance in Pancreatic Ductal Adenocarcinomas by Upregulating N-Linked Glycosylation of CDK11p110.” Cancer Letters 500 (March): 228–43. doi:10.1016/j.canlet.2020.12.006.